CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas

Authors: Romain Appay, Caroline Dehais, Claude-Alain Maurage, Agusti Alentorn, Catherine Carpentier, Carole Colin, François Ducray, Fabienne Escande, Ahmed Idbaih, Aurélie Kamoun, Yannick Marie, Karima Mokhtari, Emeline Tabouret, Nesrine Trabelsi, Emmanuelle Uro-Coste, Jean-Yves Delattre, Dominique Figarella-Branger,

Published: 2019-07-11

DOI: 10.1093/neuonc/noz124

Source: Full article

CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas

Abstract